Needle Free Injection Systems Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL NEEDLE FREE INJECTION SYSTEMS INDUSTRY

2.1 Summary about Needle Free Injection Systems Industry

2.2 Needle Free Injection Systems Market Trends

2.2.1 Needle Free Injection Systems Production & Consumption Trends

2.2.2 Needle Free Injection Systems Demand Structure Trends

2.3 Needle Free Injection Systems Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Liquid-Based Needle-Free Injectors

4.2.2 Projectile/Depot-Based Needle-Free Injectors

4.2.3 Powder-Based Needle Free Injectors

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Vaccine Delivery

4.3.2 Insulin Delivery

4.3.3 Oncology

4.3.4 Pain Management

4.3.5 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Liquid-Based Needle-Free Injectors

5.2.2 Projectile/Depot-Based Needle-Free Injectors

5.2.3 Powder-Based Needle Free Injectors

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Vaccine Delivery

5.3.2 Insulin Delivery

5.3.3 Oncology

5.3.4 Pain Management

5.3.5 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Liquid-Based Needle-Free Injectors

6.2.2 Projectile/Depot-Based Needle-Free Injectors

6.2.3 Powder-Based Needle Free Injectors

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Vaccine Delivery

6.3.2 Insulin Delivery

6.3.3 Oncology

6.3.4 Pain Management

6.3.5 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Liquid-Based Needle-Free Injectors

7.2.2 Projectile/Depot-Based Needle-Free Injectors

7.2.3 Powder-Based Needle Free Injectors

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Vaccine Delivery

7.3.2 Insulin Delivery

7.3.3 Oncology

7.3.4 Pain Management

7.3.5 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Liquid-Based Needle-Free Injectors

8.2.2 Projectile/Depot-Based Needle-Free Injectors

8.2.3 Powder-Based Needle Free Injectors

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Vaccine Delivery

8.3.2 Insulin Delivery

8.3.3 Oncology

8.3.4 Pain Management

8.3.5 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Liquid-Based Needle-Free Injectors

9.2.2 Projectile/Depot-Based Needle-Free Injectors

9.2.3 Powder-Based Needle Free Injectors

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Vaccine Delivery

9.3.2 Insulin Delivery

9.3.3 Oncology

9.3.4 Pain Management

9.3.5 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Antares Pharma, Inc. (U.S.)

10.1.2 Endo International plc (U.S.)

10.1.3 PharmaJet (U.S)

10.1.4 Bioject Medical Technologies Inc. (U.S)

10.1.5 Medical International Technology, Inc. (U.S)

10.1.6 INJEX Pharma AG (Germany)

10.1.7 National Medical Products Inc. (U.S.)

10.1.8 Valeritas, Inc. (U.S.)

10.1.9 European Pharma Group (Netherland)

10.1.10 PenJet Corporation (U.S)

10.1.11 Crossject SA (France)

10.2 Needle Free Injection Systems Sales Date of Major Players (2017-2020e)

10.2.1 Antares Pharma, Inc. (U.S.)

10.2.2 Endo International plc (U.S.)

10.2.3 PharmaJet (U.S)

10.2.4 Bioject Medical Technologies Inc. (U.S)

10.2.5 Medical International Technology, Inc. (U.S)

10.2.6 INJEX Pharma AG (Germany)

10.2.7 National Medical Products Inc. (U.S.)

10.2.8 Valeritas, Inc. (U.S.)

10.2.9 European Pharma Group (Netherland)

10.2.10 PenJet Corporation (U.S)

10.2.11 Crossject SA (France)

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Needle Free Injection Systems Product Type Overview

Table Needle Free Injection Systems Product Type Market Share List

Table Needle Free Injection Systems Product Type of Major Players

Table Brief Introduction of Antares Pharma, Inc. (U.S.)

Table Brief Introduction of Endo International plc (U.S.)

Table Brief Introduction of PharmaJet (U.S)

Table Brief Introduction of Bioject Medical Technologies Inc. (U.S)

Table Brief Introduction of Medical International Technology, Inc. (U.S)

Table Brief Introduction of INJEX Pharma AG (Germany)

Table Brief Introduction of National Medical Products Inc. (U.S.)

Table Brief Introduction of Valeritas, Inc. (U.S.)

Table Brief Introduction of European Pharma Group (Netherland)

Table Brief Introduction of PenJet Corporation (U.S)

Table Brief Introduction of Crossject SA (France)

Table Products & Services of Antares Pharma, Inc. (U.S.)

Table Products & Services of Endo International plc (U.S.)

Table Products & Services of PharmaJet (U.S)

Table Products & Services of Bioject Medical Technologies Inc. (U.S)

Table Products & Services of Medical International Technology, Inc. (U.S)

Table Products & Services of INJEX Pharma AG (Germany)

Table Products & Services of National Medical Products Inc. (U.S.)

Table Products & Services of Valeritas, Inc. (U.S.)

Table Products & Services of European Pharma Group (Netherland)

Table Products & Services of PenJet Corporation (U.S)

Table Products & Services of Crossject SA (France)

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Needle Free Injection Systems Market Forecast (Million USD) by Region 2021f-2026f

Table Global Needle Free Injection Systems Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Needle Free Injection Systems Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Needle Free Injection Systems Market Forecast (Million USD) Share by Demand 2021f-2026f